Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.30p -2.39% 53.20p 52.00p 56.00p 54.50p 54.00p 54.50p 86,921 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 0.6 -8.9 -10.1 - 76.33

Angle Share Discussion Threads

Showing 48751 to 48774 of 48775 messages
Chat Pages: 1951  1950  1949  1948  1947  1946  1945  1944  1943  1942  1941  1940  Older
DateSubjectAuthorDiscuss
23/1/2019
16:05
Monitor says 56p offer but real offer is 53.4p Quite a difference
dave4545
23/1/2019
12:49
That's partially true but remember that medicines have a patent lifespan and sooner or later generic versions come on to the market and eat away at Pharma's income on that particular medicine. They could probably charge a lot more for a medicine that really works and parsortix can help establish that early on in medicine development thus saving time and money.
jelenko
23/1/2019
10:25
I like to think of it as an exceptionally simple and effective tool for isolating elements within a fluid - it's performance eclipses any previous competitors. Its application potential continues to grow with each new area in which it demonstrates unprecedented efficacy - wherein lies part of the problem. The ability to detect problems early is a win for the individual and institutions such as the NHS but not for organisations that reap colossal profits from providing ongoing medical care or drugs to treat or contain the problem - sadly, their interests lie in perpetuating their income stream (or so they think).
spaceparallax
22/1/2019
20:16
My concern is that some still see angle as drug discovery etc. I prefer to look at the company as the 1st printer and cartridge system, that can harvest cells for you and your family :-)
l0ngterm
22/1/2019
20:01
FWIW I do a mixture of trading and longer term investing. I don't have any one particular type of stock I buy. I have about 5% of my funds in these blue sky punts and for those I look for stocks where the market cap is relatively low and the product seems to be far enough on the way to commercialisation that I hope not to be holding for 10 or 15 years through dilutive fundraising after dilutive fundraising. So basically a balance between risk and reward. In Angle's case we should hear this year AIUI whether or not the breast cancer trial was a success and may also get more surprises like the one we had the other day which expand the potential applications for Parsotix. One thing I do know is if the Breast Cancer trial is a failure then I will sell and take back what's left of my investment. It's harder to know what i'll do if it's a success, there is a lot of M&A activity at the moment in oncology and if some sort of bidding war broke out for Angle then i'd hope we'd all do very nicely.
arthur_lame_stocks
22/1/2019
19:28
Space: the key point is that investors/traders are saying this is going up. To me there is no point in debating tactics. Reading this thread I have seen folk seriously assessing this as an investment and reviewing the potential market and there position. Based upon this IMHO the holders will win overall, as news is primed and the lack of a significant drop will catch a few traders on the hop. I am sure Dave et al. have seen this before (no negativity meant to each strategy).
l0ngterm
22/1/2019
17:35
Dave, I understand what you're saying but it's simply perpetuating the problem. As with pure gambling, in trading the only winners in the medium to long term are those that handle the transactions and cream off a thin slice. Were trading to be restricted by say applying a mandatory holding period then market volatility would be significantly reduced resulting in net benefits to genuine investors and companies alike. Let there be no misunderstanding, I'm all for SPs reflecting genuine performance and an element of perceived future value but as we all know with smallcaps, trading facilitates irrational swings in response to news, spurious news and often modest volumes. The film The Big Short was a wonderful insight into the corrupt nature of the so-called free markets, where checks and balances were given a blind eye by those in a position of responsibility because it wasn't in their perceived short or medium term interest. As we all know the banking crisis was triggered by the coming home to roost of the gambles that banks had taken because they had enjoyed years of gains from the golden goose and were happy to overlook its welfare, which had become lost from sight amongst the smoke and mirrors of financial instruments. Sadly our society appears not to have learned (or at best only partly learned) from such a cataclysmic failure, for which most world economies continue to pay the price. We should be addressing not just the known failings but asking whether those lessons can be justifiably applied in other arenas. Most unfortunately of all, those at the bottom of the heap seem to suffer most each time. Anyway, I think I've said more than enough for one day.
spaceparallax
22/1/2019
16:11
Not sure I've noticed this one before. hTtps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32092 Microfluidic enrichment, isolation and characterization of disseminated melanoma cells from lymph node samples We demonstrate the feasibility of epitope‐independent isolation of LN DCCs using Parsortix™ for subsequent molecular characterization of isolated single DCCs with ample application fields including the use for companion diagnostics or subsequent cellular studies in personalized medicine.
waterloo01
22/1/2019
15:33
54.5p mid price to buy at the moment. Paying nearly 57p earlier
dave4545
22/1/2019
13:29
Where are these U.S. investors to whom AN referred in the recent Proactive video?
semper vigilans
22/1/2019
12:27
space A lot of investors have had to adapt and become part time traders. If you know a share is swamped with day traders like Agl was when it hit 75p then surely you think it's worth selling a small % of your holding and buying back cheaper. There was a massive 25p swing between the high and then the low following the exciting news. On 25k that is £6000 profit to be made selling and buying back while remaining a core holding.
dave4545
22/1/2019
11:48
Fair call Space.
semper vigilans
22/1/2019
11:39
I'm here as an investor because I believe in the Parsortix system and feel reassured by the steady flow of positive results in an everexpanding arena of applications. Trading is what f....s up the mkt and whilst it might give occasional success, it will also yield plenty of loss in worth or opportunity. In a rational world, investing in products like Parsortix should pay off eventually despite the obstacles placed in our way by administrative bodies who are in hock to Big Pharma who perceive Parsortix as a threat to their gravy train; this might be true to a degree but if only they could buy into the complementary nature of Parsortix then hundreds of millions of citizens around the world could benefit. Sadly big business doesn't think that way - it's in their MBA DNA to grow at all costs, irrespective of the carnage wreaked within their industry and the impact on society, and the so called free market, of their ruthless monopolistic designs. Fortunately, we are now seeing many practitioners of such policies beginning to fail on the UK high street. Sadly, it's the generally innocent employees who are impacted most by the megalomanic desires of the rapacious, self-serving directors. Hopefully in time, society will come to recognise that the current system is being amply proven not to work and that alternative thinking such as Doughnut Economics (Kate Raworth) or the ideas of Mariana Mazzucato are a better way forward to serve Society. It takes a paradigm shift but the above authors are really worth reading.
spaceparallax
22/1/2019
10:45
I suspect there will be good news next Thursday with the interims. The breast cancer trials must be close to finishing. There are so many irons in the fire at the moment. Any one of them could trigger a sudden rise in the share price. The risk is being out of and not in this stock at the moment imo.
mikepompeyfan
22/1/2019
09:31
Sadly it's 99% of the market now. Even if you are long term it would have been wise to trade a few at 75p and buyback at 55p. Long term if they deliver you know where it's heading but in this market there will be wild swings Nothing offered online at 55p now
dave4545
22/1/2019
09:29
“InvestorsR21; not “traders”; would be even better.
semper vigilans
22/1/2019
09:20
Be quite a few traders watching for this turning again to get in ahead of the next bounce.
dave4545
21/1/2019
22:17
£20 more like
dave4545
21/1/2019
22:02
Of what relevance is your net worth to us, le baboon?
thailand
21/1/2019
21:44
I will happily buy 5000 of your shares @25p so you get a 20% premium lol
millwallfan
21/1/2019
21:35
ooh ooh ooh eee eee eee aah aah aah ooh ooh ooh eee eee eee aah aah aah 20p ooh ooh ooh eee eee eee aah aah aah 20p ooh ooh ooh eee eee eee aah aah aah 20p
le baboon
21/1/2019
15:59
Certain buy order. Drops to 52p earlier now back to 52.5p despite that 15k sale and I can sell 50k online at 52.5p
dave4545
21/1/2019
09:11
Guess there is a buy order in the system. 52.25p bid Friday mostly sales all took. 52.5p sale this morning one small trade and now 52.55p bid so bid rising after sales usually means buy order.
dave4545
20/1/2019
13:38
Thanks 4legs. Looks like using CTC's as a tool to investigate CUPs may be something that Angle have identified as a potentially significant application for Parsortix.
miavoce
Chat Pages: 1951  1950  1949  1948  1947  1946  1945  1944  1943  1942  1941  1940  Older
Your Recent History
LSE
AGL
Angle
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190124 04:31:00